Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2020 | $390,921 | | tax credit/rebate |
GLAXOSMITHKLINE & Stiefel Laboratories Inc. | GlaxoSmithKline | New York | local | 2020 | $588,821 | | tax credit/rebate |
LAX/Amneal Pharmaceuticals | Amneal Pharmaceuticals | New York | local | 2020 | $218,068 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $788,701 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2020 | $894,247 | | tax credit/rebate |
Regeneron CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2020 | $361,165 | | tax credit/rebate |
Regeneron Columbia Project | Regeneron Pharmaceuticals | New York | local | 2020 | $192,947 | | tax credit/rebate |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2020 | $951,284 | | tax credit/rebate |
Regeneron Garage | Regeneron Pharmaceuticals | New York | local | 2020 | $99,157 | | tax credit/rebate |
Regeneron Garage Addition 25 Discovery Dr. | Regeneron Pharmaceuticals | New York | local | 2020 | $46,384 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2020 | $74,036 | | tax credit/rebate |
Regeneron Pharmaceuticals III | Regeneron Pharmaceuticals | New York | local | 2020 | $991,620 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2020 | $201,254 | | tax credit/rebate |
Regeneron Warehouse | Regeneron Pharmaceuticals | New York | local | 2020 | $1,007,951 | | tax credit/rebate |
Regeneron Warehouse Expansion | Regeneron Pharmaceuticals | New York | local | 2020 | $3,300,130 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2020 | $326,753 | | tax credit/rebate |
Johnson & Johnson Vision Care, Inc. | Johnson & Johnson | Florida | local | 2021 | $7,000,000 | | grant |
Supernus Pharmaceuticals | Supernus Pharmaceuticals | Maryland | local | 2019 | $500,000 | | grant/loan hybrid program |
Novavax, Inc. | Novavax Inc. | Maryland | local | 2020 | $1,000,000 | | grant/loan hybrid program |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2020 | $210,812 | | tax credit/rebate |
Bausch & Lomb Inc. | Bausch Health | New York | local | 2020 | $1,076,396 | | tax credit/rebate |
Regeneron 1 CSC Way Project | Regeneron Pharmaceuticals | New York | local | 2020 | $361,165 | | tax credit/rebate |
Regeneron 81 Columbia Project | Regeneron Pharmaceuticals | New York | local | 2020 | $192,947 | | tax credit/rebate |
RegeneronN | Regeneron Pharmaceuticals | New York | local | 2020 | $878,388 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2020 | $3,137,267 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2021 | $167,626 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2021 | $795,000 | | tax credit/rebate |
American Pharmaceutical Partners, Inc. | Bristol-Myers Squibb | New York | local | 2021 | $6,481 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $184,567 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2021 | $97,120 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2021 | $156,185 | | tax credit/rebate |
Regeneron 1CSC Office/Lab Extension | Regeneron Pharmaceuticals | New York | local | 2021 | $103,392 | | tax credit/rebate |
RegeneronN | Regeneron Pharmaceuticals | New York | local | 2021 | $3,713,660 | | tax credit/rebate |
Regeneron 300 Valley View | Regeneron Pharmaceuticals | New York | local | 2021 | $119,479 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2021 | $121,874 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2021 | $261,116 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2021 | $4,324,671 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2021 | $390,427 | | tax credit/rebate |
Emergent Biosolutions | Emergent BioSolutions | Maryland | local | 2014 | $250,000 | | infrastructure assistance |
Allergan Inc. | AbbVie | Texas | local | 2012 | undisclosed | | grant |
Regeneron Building D | Regeneron Pharmaceuticals | New York | local | 2022 | $2,171,758 | | tax credit/rebate |
Bristol-Myers Squibb | Bristol-Myers Squibb | New York | local | 2022 | $336,050 | | tax credit/rebate |
Steel Forest, LLC | AbbVie | New York | local | 2022 | $264,555 | | tax credit/rebate |
Amneal (50 Horseblock-NM AMNL) | Amneal Pharmaceuticals | New York | local | 2022 | $226,608 | | tax credit/rebate |
Amneal Pharmaceuticals LLC 2019 Facility | Amneal Pharmaceuticals | New York | local | 2022 | $169,333 | | tax credit/rebate |
Regeneron Pharmaceuticals | Regeneron Pharmaceuticals | New York | local | 2022 | $133,565 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $116,856 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $113,118 | | tax credit/rebate |
Bausch & Lomb Incorporated | Bausch Health | New York | local | 2022 | $75,893 | | tax credit/rebate |
Regeneron Phase II (aka LOOP Road project) | Regeneron Pharmaceuticals | New York | local | 2022 | $74,201 | | tax credit/rebate |
Regeneron | Regeneron Pharmaceuticals | New York | local | 2022 | $63,375 | | tax credit/rebate |
Regeneron Pharmaceuticals II | Regeneron Pharmaceuticals | New York | local | 2022 | $24,434 | | tax credit/rebate |
Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals | New York | local | 2022 | $22,434 | | tax credit/rebate |
Genentech Inc | Roche | Oregon | local | 2023 | $3,134,511 | | property tax abatement |
L. Perrigo Company | Perrigo | Michigan | local | 2021 | undisclosed | | property tax abatement |
Millipore Corporation | Merck KGaA (EMD) | United States | federal | 2009 | $608,447 | | federal grant |
EMD Serono Research Center, Inc. | Merck KGaA (EMD) | United States | federal | 2011 | $31,419 | | federal grant |
AstraZeneca Pharmaceuticals LP | AstraZeneca | United States | federal | 2012 | $2,713,491 | | federal grant |
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $4,011,709 | | federal grant |
HI TECH Pharmacal Company | Akorn Inc. | United States | federal | 2012 | $603,688 | | federal grant |
GlaxoSmithKline | GlaxoSmithKline | United States | federal | 2012 | $729,692 | | federal grant |
Morphotek, Inc. | Eisai | United States | federal | 2012 | $141,901 | | federal grant |
Astellas US LLC | Astellas Pharma | United States | federal | 2013 | $1,160,482 | | federal grant |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $360,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2008 | | $450,000 | federal loan or loan guarantee |
Biosite Incorporated | Abbott Laboratories | United States | federal | 2007 | | $270,000 | federal loan or loan guarantee |
Cholestech Corporation | Abbott Laboratories | United States | federal | 2007 | | $1,500,000 | federal loan or loan guarantee |
Gilead Sciences, Inc. | Gilead Sciences | United States | federal | 2011 | | $4,500,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2013 | | $3,375,000 | federal loan or loan guarantee |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2014 | | $3,375,000 | federal loan or loan guarantee |
Novozymes Blair, Inc. | Novo Holdings A/S | United States | federal | 2010 | $28,401,000 | | federal allocated tax credit |
Megadyne Medical Products, Inc. | Johnson & Johnson | United States | federal | 2015 | | $4,050,000 | federal loan or loan guarantee |
Sanofi Pasteur Vaxdesign Corp | Sanofi | United States | federal | 2010 | $1,499,990 | | federal grant |
Easel Biotechnologies, LLC | Bristol-Myers Squibb | United States | federal | 2014 | $1,201,621 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2008 | $4,694,082 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2008 | $9,994,970 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2009 | $24,341,409 | | federal grant |
Novozymes, Inc. | Novo Holdings A/S | United States | federal | 2013 | $2,500,000 | | federal grant |
Amyris, Inc. | Amyris | United States | federal | 2016 | $3,549,805 | | federal grant |
Novozymes North America, Inc. | Novo Holdings A/S | United States | federal | 2011 | $1,568,670 | | federal grant |
Silarx Pharmaceuticals, Inc | Lannett Co. | United States | federal | 2012 | | $2,138,000 | federal loan or loan guarantee |
Wyeth, Inc. | Pfizer | United States | federal | 2019 | | $3,542,000 | federal loan or loan guarantee |